MD, PhD
Assistant Professor, Medicine, Hematology/Oncology
UNC-Chapel Hill
Immunology and Immunotherapy Research Program
Area of Interest
I am interested in the development and application of cellular therapies for multiple myeloma and beyond. My background of research is in the development of a novel CD64 CAR-T cell therapy for venetoclax-resistant AML.
With this experience applied to my clinical interest in multiple myeloma and healthcare advocacy, I aim to improve outcomes and access to novel cellular therapies for patients with multiple myeloma and other malignancies through clinical and translational research.
Awards and Honors
- Invited Speaker, Bispecifics vs CAR-T in Relapsed/Refractory Multiple Myeloma, Rocky Mountain Multiple Myeloma Rounds, 2024
- First Place, Faculty Poster Presentation; University of Colorado Cancer Center Scientific Retreat, 2024
- Mentor of Medical Student Abstract Award Winner, American Society of Hematology, 2024
- Abstract Award, American Society of Hematology, 2023
- Humanism of Cancer Care: Schwartz Rounds, University of Colorado, 2023
- Keynote speaker, Colorado Association of Family Medicine Residencies Annual Rocky Mountain Research Forum, 2023
- Milton Sacks Award in Hematology, University of Maryland School of Medicine, 2019
- Abstract Award, American Society of Hematology, 2016
